Diamyd Medical AB

Diamyd Medical AB
Stock Exchange First North Sweden
EPS
SEK0.68
Market Cap
SEK451.8 M
Shares Outstanding
54.2 M
Public Float
-

Profile

Address
Kungsgatan 29
Stockholm AB 111 56
Sweden
Employees -
Website http://www.diamyd.com
Updated 09/14/2018
Diamyd Medical AB engages in the development of pharmaceutical products for the treatment of diabetes. It develops vaccine to cure autoimmune diabetes. The firm also involves in investment in medical and stem cell technology.

Financials

View All
Created with Highcharts 5.0.14Diamyd Medical ABNet Income. Fiscal year is September-August. All values SEK Thousands.12 63312 63316 03416 03421 39721 39732 00832 00825 55525 55520132014201520162017010k20k30k40k
Created with Highcharts 5.0.14Diamyd Medical ABSales/Revenue. Fiscal year is September-August. All values SEK Thousands.1001004434435135137577579229222013201420152016201702505007501000

Maria-Teresa Essen-Möller
Director
Anders Essen-Möller
Director